Global RNA-Based Therapeutics and Vaccines Market Research Report 2023

Report ID: 1992444 | Published Date: Oct 2024 | No. of Page: 92 | Base Year: 2023 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 RNA-Based Therapeutics
        1.2.3 RNA-Based Vaccines
    1.3 Market by Application
        1.3.1 Global RNA-Based Therapeutics and Vaccines Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Immunology
        1.3.4 Ophthalmology
        1.3.5 Cardiovascular Diseases
        1.3.6 Infectious Diseases
        1.3.7 Genetic Diseases
        1.3.8 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global RNA-Based Therapeutics and Vaccines Market Perspective (2017-2028)
    2.2 RNA-Based Therapeutics and Vaccines Growth Trends by Region
        2.2.1 RNA-Based Therapeutics and Vaccines Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 RNA-Based Therapeutics and Vaccines Historic Market Size by Region (2017-2022)
        2.2.3 RNA-Based Therapeutics and Vaccines Forecasted Market Size by Region (2023-2028)
    2.3 RNA-Based Therapeutics and Vaccines Market Dynamics
        2.3.1 RNA-Based Therapeutics and Vaccines Industry Trends
        2.3.2 RNA-Based Therapeutics and Vaccines Market Drivers
        2.3.3 RNA-Based Therapeutics and Vaccines Market Challenges
        2.3.4 RNA-Based Therapeutics and Vaccines Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue
        3.1.1 Global Top RNA-Based Therapeutics and Vaccines Players by Revenue (2017-2022)
        3.1.2 Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Players (2017-2022)
    3.2 Global RNA-Based Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by RNA-Based Therapeutics and Vaccines Revenue
    3.4 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio
        3.4.1 Global RNA-Based Therapeutics and Vaccines Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by RNA-Based Therapeutics and Vaccines Revenue in 2021
    3.5 RNA-Based Therapeutics and Vaccines Key Players Head office and Area Served
    3.6 Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
    3.7 Date of Enter into RNA-Based Therapeutics and Vaccines Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 RNA-Based Therapeutics and Vaccines Breakdown Data by Type
    4.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Type (2017-2022)
    4.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2023-2028)
5 RNA-Based Therapeutics and Vaccines Breakdown Data by Application
    5.1 Global RNA-Based Therapeutics and Vaccines Historic Market Size by Application (2017-2022)
    5.2 Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    6.2 North America RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
    6.3 North America RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    7.2 Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
    7.3 Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    8.2 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
    8.3 Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    9.2 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
    9.3 Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size (2017-2028)
    10.2 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022)
    10.3 Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Alnylam Pharmaceuticals
        11.1.1 Alnylam Pharmaceuticals Company Detail
        11.1.2 Alnylam Pharmaceuticals Business Overview
        11.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
        11.1.4 Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.1.5 Alnylam Pharmaceuticals Recent Development
    11.2 Arbutus Biopharma
        11.2.1 Arbutus Biopharma Company Detail
        11.2.2 Arbutus Biopharma Business Overview
        11.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Introduction
        11.2.4 Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.2.5 Arbutus Biopharma Recent Development
    11.3 Arrowhead Pharmaceuticals
        11.3.1 Arrowhead Pharmaceuticals Company Detail
        11.3.2 Arrowhead Pharmaceuticals Business Overview
        11.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
        11.3.4 Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.3.5 Arrowhead Pharmaceuticals Recent Development
    11.4 BioNTech
        11.4.1 BioNTech Company Detail
        11.4.2 BioNTech Business Overview
        11.4.3 BioNTech RNA-Based Therapeutics and Vaccines Introduction
        11.4.4 BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.4.5 BioNTech Recent Development
    11.5 CureVac
        11.5.1 CureVac Company Detail
        11.5.2 CureVac Business Overview
        11.5.3 CureVac RNA-Based Therapeutics and Vaccines Introduction
        11.5.4 CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.5.5 CureVac Recent Development
    11.6 Dicerna Pharmaceuticals
        11.6.1 Dicerna Pharmaceuticals Company Detail
        11.6.2 Dicerna Pharmaceuticals Business Overview
        11.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
        11.6.4 Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.6.5 Dicerna Pharmaceuticals Recent Development
    11.7 Regulus Therapeutics
        11.7.1 Regulus Therapeutics Company Detail
        11.7.2 Regulus Therapeutics Business Overview
        11.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Introduction
        11.7.4 Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.7.5 Regulus Therapeutics Recent Development
    11.8 Marina Biotech
        11.8.1 Marina Biotech Company Detail
        11.8.2 Marina Biotech Business Overview
        11.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Introduction
        11.8.4 Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.8.5 Marina Biotech Recent Development
    11.9 MiRagen Therapeutics
        11.9.1 MiRagen Therapeutics Company Detail
        11.9.2 MiRagen Therapeutics Business Overview
        11.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Introduction
        11.9.4 MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.9.5 MiRagen Therapeutics Recent Development
    11.10 Moderna Therapeutics
        11.10.1 Moderna Therapeutics Company Detail
        11.10.2 Moderna Therapeutics Business Overview
        11.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Introduction
        11.10.4 Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.10.5 Moderna Therapeutics Recent Development
    11.11 Quark Pharmaceuticals
        11.11.1 Quark Pharmaceuticals Company Detail
        11.11.2 Quark Pharmaceuticals Business Overview
        11.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Introduction
        11.11.4 Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.11.5 Quark Pharmaceuticals Recent Development
    11.12 Roche
        11.12.1 Roche Company Detail
        11.12.2 Roche Business Overview
        11.12.3 Roche RNA-Based Therapeutics and Vaccines Introduction
        11.12.4 Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.12.5 Roche Recent Development
    11.13 Sylentis
        11.13.1 Sylentis Company Detail
        11.13.2 Sylentis Business Overview
        11.13.3 Sylentis RNA-Based Therapeutics and Vaccines Introduction
        11.13.4 Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022)
        11.13.5 Sylentis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global RNA-Based Therapeutics and Vaccines Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of RNA-Based Therapeutics
    Table 3. Key Players of RNA-Based Vaccines
    Table 4. Global RNA-Based Therapeutics and Vaccines Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global RNA-Based Therapeutics and Vaccines Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global RNA-Based Therapeutics and Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global RNA-Based Therapeutics and Vaccines Market Share by Region (2017-2022)
    Table 8. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global RNA-Based Therapeutics and Vaccines Market Share by Region (2023-2028)
    Table 10. RNA-Based Therapeutics and Vaccines Market Trends
    Table 11. RNA-Based Therapeutics and Vaccines Market Drivers
    Table 12. RNA-Based Therapeutics and Vaccines Market Challenges
    Table 13. RNA-Based Therapeutics and Vaccines Market Restraints
    Table 14. Global RNA-Based Therapeutics and Vaccines Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global RNA-Based Therapeutics and Vaccines Market Share by Players (2017-2022)
    Table 16. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2021)
    Table 17. Ranking of Global Top RNA-Based Therapeutics and Vaccines Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by RNA-Based Therapeutics and Vaccines Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players RNA-Based Therapeutics and Vaccines Product Solution and Service
    Table 21. Date of Enter into RNA-Based Therapeutics and Vaccines Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global RNA-Based Therapeutics and Vaccines Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2017-2022)
    Table 25. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Type (2023-2028)
    Table 27. Global RNA-Based Therapeutics and Vaccines Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application (2017-2022)
    Table 29. Global RNA-Based Therapeutics and Vaccines Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global RNA-Based Therapeutics and Vaccines Revenue Market Share by Application (2023-2028)
    Table 31. North America RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Alnylam Pharmaceuticals Company Detail
    Table 42. Alnylam Pharmaceuticals Business Overview
    Table 43. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
    Table 44. Alnylam Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 45. Alnylam Pharmaceuticals Recent Development
    Table 46. Arbutus Biopharma Company Detail
    Table 47. Arbutus Biopharma Business Overview
    Table 48. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product
    Table 49. Arbutus Biopharma Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 50. Arbutus Biopharma Recent Development
    Table 51. Arrowhead Pharmaceuticals Company Detail
    Table 52. Arrowhead Pharmaceuticals Business Overview
    Table 53. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
    Table 54. Arrowhead Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 55. Arrowhead Pharmaceuticals Recent Development
    Table 56. BioNTech Company Detail
    Table 57. BioNTech Business Overview
    Table 58. BioNTech RNA-Based Therapeutics and Vaccines Product
    Table 59. BioNTech Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 60. BioNTech Recent Development
    Table 61. CureVac Company Detail
    Table 62. CureVac Business Overview
    Table 63. CureVac RNA-Based Therapeutics and Vaccines Product
    Table 64. CureVac Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 65. CureVac Recent Development
    Table 66. Dicerna Pharmaceuticals Company Detail
    Table 67. Dicerna Pharmaceuticals Business Overview
    Table 68. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product
    Table 69. Dicerna Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 70. Dicerna Pharmaceuticals Recent Development
    Table 71. Regulus Therapeutics Company Detail
    Table 72. Regulus Therapeutics Business Overview
    Table 73. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product
    Table 74. Regulus Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 75. Regulus Therapeutics Recent Development
    Table 76. Marina Biotech Company Detail
    Table 77. Marina Biotech Business Overview
    Table 78. Marina Biotech RNA-Based Therapeutics and Vaccines Product
    Table 79. Marina Biotech Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 80. Marina Biotech Recent Development
    Table 81. MiRagen Therapeutics Company Detail
    Table 82. MiRagen Therapeutics Business Overview
    Table 83. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product
    Table 84. MiRagen Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 85. MiRagen Therapeutics Recent Development
    Table 86. Moderna Therapeutics Company Detail
    Table 87. Moderna Therapeutics Business Overview
    Table 88. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product
    Table 89. Moderna Therapeutics Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 90. Moderna Therapeutics Recent Development
    Table 91. Quark Pharmaceuticals Company Detail
    Table 92. Quark Pharmaceuticals Business Overview
    Table 93. Quark Pharmaceuticals RNA-Based Therapeutics and VaccinesProduct
    Table 94. Quark Pharmaceuticals Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 95. Quark Pharmaceuticals Recent Development
    Table 96. Roche Company Detail
    Table 97. Roche Business Overview
    Table 98. Roche RNA-Based Therapeutics and VaccinesProduct
    Table 99. Roche Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 100. Roche Recent Development
    Table 101. Sylentis Company Detail
    Table 102. Sylentis Business Overview
    Table 103. Sylentis RNA-Based Therapeutics and VaccinesProduct
    Table 104. Sylentis Revenue in RNA-Based Therapeutics and Vaccines Business (2017-2022) & (US$ Million)
    Table 105. Sylentis Recent Development
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global RNA-Based Therapeutics and Vaccines Market Share by Type: 2021 VS 2028
    Figure 2. RNA-Based Therapeutics Features
    Figure 3. RNA-Based Vaccines Features
    Figure 4. Global RNA-Based Therapeutics and Vaccines Market Share by Application in 2021 & 2028
    Figure 5. Oncology Case Studies
    Figure 6. Immunology Case Studies
    Figure 7. Ophthalmology Case Studies
    Figure 8. Cardiovascular Diseases Case Studies
    Figure 9. Infectious Diseases Case Studies
    Figure 10. Genetic Diseases Case Studies
    Figure 11. Others Case Studies
    Figure 12. RNA-Based Therapeutics and Vaccines Report Years Considered
    Figure 13. Global RNA-Based Therapeutics and Vaccines Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global RNA-Based Therapeutics and Vaccines Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global RNA-Based Therapeutics and Vaccines Market Share by Region: 2021 VS 2028
    Figure 16. Global RNA-Based Therapeutics and Vaccines Market Share by Players in 2021
    Figure 17. Global Top RNA-Based Therapeutics and Vaccines Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA-Based Therapeutics and Vaccines as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by RNA-Based Therapeutics and Vaccines Revenue in 2021
    Figure 19. North America RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. North America RNA-Based Therapeutics and Vaccines Market Share by Country (2017-2028)
    Figure 21. United States RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe RNA-Based Therapeutics and Vaccines Market Share by Country (2017-2028)
    Figure 25. Germany RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific RNA-Based Therapeutics and Vaccines Market Share by Region (2017-2028)
    Figure 33. China RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Japan RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. South Korea RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Southeast Asia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. India RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Australia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America RNA-Based Therapeutics and Vaccines Market Share by Country (2017-2028)
    Figure 41. Mexico RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Brazil RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa RNA-Based Therapeutics and Vaccines Market Share by Country (2017-2028)
    Figure 45. Turkey RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Saudi Arabia RNA-Based Therapeutics and Vaccines Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Alnylam Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 48. Arbutus Biopharma Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 49. Arrowhead Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 50. BioNTech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 51. CureVac Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 52. Dicerna Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 53. Regulus Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 54. Marina Biotech Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 55. MiRagen Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 56. Moderna Therapeutics Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 57. Quark Pharmaceuticals Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 59. Sylentis Revenue Growth Rate in RNA-Based Therapeutics and Vaccines Business (2017-2022)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alnylam Pharmaceuticals
Arbutus Biopharma
Arrowhead Pharmaceuticals
BioNTech
CureVac
Dicerna Pharmaceuticals
Regulus Therapeutics
Marina Biotech
MiRagen Therapeutics
Moderna Therapeutics
Quark Pharmaceuticals
Roche
Sylentis
Frequently Asked Questions
RNA-Based Therapeutics and Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
RNA-Based Therapeutics and Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
RNA-Based Therapeutics and Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Roll Presses

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More